• Embed Doc
  • Readcast
  • Collections
  • 1
    CommentGo Back
Download
 
The presence o HBsAg aects all age groups.Indices o 10% are common in children under4 years o age. 60% o children were inected by age 10 and markers o inection (anti-HBs) canbe ound in 60% o 14-year-olds. Prior to 1994,7.4% o deaths in the State o Amazonas wereattributed to hepatitis, more than twice thosedue to Malaria (3.3%). The Amazon Brazilianbasin is also a high endemic area or hepatitisdelta virus (HDV) inection, with a prevalenceo 26.9 %, whereas it is virtually non-existent inthe rest o Brazil. Liver cirrhosis due to HBV and HDV inections is one o the ten majorcauses o death in the State o Amazonas. Several actors contribute to the disseminationo HBV in our region. Horizontal transmissionis the main mode o spread. Family contacts, ahigh need or early dental care, early sexualactivity, promiscuity, and poor socio-economicand sanitary conditions all play important rolesin the dissemination o the virus. Vertical trans-mission is surprisingly rare.
(continued on next page) 
 José Carlos Ferraz da Fonseca,Professor of Federal University of Amazonas, BrazilDepartment of Medicine Tropical and InfectiousDiseases (e-mail: jcfonseca@vivax.com.br)
Introduction
In Brazil, inection by the hepatitis B virus(HBV) is a major public health problem,particularly in some areas o the north Amazonregion and especially in the State o Amazonas.Hepatitis B inection exhibits dierent regionallevels o endemicity (gure 1). In the south andsoutheast regions o the country, the prevalenceo inection is generally low, whereas in thenortheast and the center-western regions, inec-tion rates are intermediate. Beore the programo vaccination, elevated rates o HBV carriage were ound, principally in the west. In 1998, theprevalence o asymptomatic carriers o HBsAgin the State o Amazonas was estimated to be16.7% (220,000 carriers). 
Eradication of Hepatitis B virus infection in the State of Amazonas
World Digestive Health Day:Viral Hepatitis
May 29, 2007
Figure 1.
Prevalence o hepatitis B virus in Brazilbased on HBsAg prevalence rates.
 Fonseca JCF et al, 1987) 
 A small village in the rural zone o the Stateo Amasonas, Brazil where HBV and HDV inection are endemic.
(J. Fonseca) 
Editor: Douglas R. LaBrecque, MDAsst. Editor: Molly DonohueDesign: Shawn RoachWDHD Committee Henry Cohen (Uruguay)Douglas LaBrecque (USA)Co-ChairmenSiham Mostafa Abdulrehim (Alexandria)Gamal Esmat (Egypt) Jozef Glaza (Slovak Republic)Saeed Hamid (Pakistan)Waseem Hamoudi (Jordan) Jozef Holoman (Slovak Republic)George Lau (China)Susanne Lopes (Portugal)Guilherme Macedo (Portugal)Masao Omata (Japan) Tushar Patel (USA)Shiv Sarin (India)Shivaram Prasad Singh (India)Published bytheWorld Gastroenterology Organisationwww.worldgastroenterology.orgWDHD has been endorsed by:
Asociacion Interamericana deGastroenterologia (AIGE)International Association for theStudy of the Liver (IASL)African Association for theStudy of Liver Diseases (AfASLD)HEALS of the SouthNational Coalition of STD Directors The Hepatitis C Caring AmbassadorsProgram The Hepatitis C Trust The Hepatitis Support Association The Title II Community AIDS National Network This newsletter received unrestricted supportfrom Concordat members Alcona/Nycomed andOlympus as well as Schering-Plough
 
Strategies to control Hepatitis B infection in theState of Amazonas, Brazil.
Based on this inormation, we devel-oped a project to control HBV inectionin the State o Amazonas in September1987. This project was supported by the Brazilian Ministry o Health and Amazonas Government. The authorso this Project were: José Carlos Fer-raz da Fonseca, Leila Melo Brasil and Wornei Miranda Braga (researchers o the Fundação de Medicina Tropical do Amazonas). Strategies were based onrecommendations made by the ViralHepatitis Consultative Commission o the Ministry o Health, Brazil. In 1988,our rst task was to develop a program which educated local populations livingin 11 hyperendemic areas about thebenets o immunization. The program was implemented in two phases. Phase I In hyper-endemic areas o HBV and HDV inection, including the ruraland urban populations o 11 counties,all children 0 to 9 years old were vac-cinated (without previous screening).The target group included 27,893 inurban areas and 56,127 in rural areas.In Phase II, vaccination was gradually extended to the remaining counties o the western Amazon region, vaccinatingchildren 0-4 years o age.Following these campaigns, vaccination was targeted toward: a) all newborns(integration o the vaccine into theNational Programme o Immunization);b) immigrants to the north Amazonarea; c) all health care providers;d) multi transused patients; e) chronicrenal disease patients undergoing dialy-sis; ) Hansen’s disease patients;g) institutionalized (high risk patients);i) those o Asian origin; j) military personnel; k) indigenous populations;l) householders o HBsAg positivepeople; m) high risk groups (malehomosexuals, sex workers, intravenousdrug abusers). In October, 1989 (urban area), the vac-cination program against HBV inec-tion was initiated, using three doses,10 mcg recombinant DNA hepatitis B vaccine, on a 0, 1, 6 month vaccinationschedule. In January, 1990 the program was extended to the rural areas. Parallelto this special program, we conducteda pilot study to evaluate the immuno-genicity o two dierent doses (10 mcgand 20 mcg) o this vaccine in the vil-lage o Codajás (Solimões River, State o  Amazonas), an HBV and HDV hyperen-demic area. Ater one year this special program was extended to 14 municipalities inthe State o Amazonas, along with theinitiation o the vaccination programamong health workers. During 1991, the vaccination program covered all chil-dren rom 0 to 4 years old living in the60 municipalities in our area. In 1992the vaccine against HBV inection wasintegrated into the Regional Program o Immunization o the State o Amazonas,Brazil. HBV vaccination was incorpo-rated into the National Program o Immunization in 1995, including PublicHealth workers and high risk groups o patients.
Results of hepatitis B vaccination programin the State of Amazonas, Brazil
In the rst year, coverage o HB vac-cine (special program) was extremely high with an estimated 82,020 children vaccinated. 97.5% o the target popula-tion received the rst dose, 89.6% thesecond dose and 78.1% the third dose.Four years ater the start o vaccination,the percentageo seroconver-sion (anti-HBs> 10 IU/l) was79% (10mcg)and 95,2% (20mcg), p<0.05.High geomet-ric mean titerso antibody  were observedat 237.0 IU/Iand 610.0 IU/l with 10 mcgand 20 mcg,respectively. The high anti-HBs titersobserved in some children are probably the result o a natural booster responseater contact with HBV.By October 2006, the number o chil-dren < 1 year old ully vaccinated inthe State o Amazonas was 658,920. Inour region, rom 1994 to 2004 a total o 973,704 individuals rom 1 to 20 yearsold received three doses o vaccine. It is estimated that 45.2% o the generalpopulation living in the State o Amazo-nas have now been vaccinated.Changes in the prevalence o HBsAgcarriers and the incidence o HBV acute viral hepatitis in hyperendemic areas 10 years ater starting the immunizationprogramme (1989-1999) were dramatic.HB immunization reduced the preva-lence o carriers o HBsAg rom 15.3%to 3.7% in the village o Lábrea (Purusriver) and rom 16.7% to 5.8% in the o State o Amazonas (gure 2).Beore the mass vaccination in hyperen-demic areas, the etiology o acute hepa-titis was HBV in 51.4% and the HAV in42.1% o the cases. Ten years ater themass vaccination 94.6% o acute hepati-tis was due to HAV and only 3, 8% HBV.These results indicate that universal vac-cination o inants less than nine yearsold and the integration o HB vaccineinto the National Program o Immuniza-tion was eective in dramatically reduc-ing the endemic status o HB inectionin the general population, even in thehighly remote rural villages.
Eradication of Hepatitis B virus infection in the State of Amazonas
 
(continued)
2 WORLD DIGESTIVE HEALTH DAY: VIRAL HEPATITIS
 
E  
 very year on May 29, the World Gastroenterology Organisation celebrates “World Digestive Health Day” in order todraw the attention o the global medical community to an urgent and overlooked world health issue. In 2007, we will spot-light viral hepatitis. Almost 400 million people are chronically inected with hepatitis B, and about 200 million are chroni-cally inected with hepatitis C; together, these diseases are responsible or the majority o hepatocellular cancer cases, thethird leading cause o cancer death worldwide. A number o projects are planned or World Digestive Health Day 2007: Viral Hepatitis. We thank the members o the WDHD committee and the multiple authors and national societies who havecontributed to the many projects listed below.
WDHD Newsletter
This newsletter is intended to put a human ace on viral hepatitis. It will be distributed during Digestive Diseases Week 2007and on the WGO website. This publication tells “the story o hepatitis” in various countries around the world, ocusing onproblems in individual countries and eorts to solve them. We have gathered and edited articles and photographs that provide an overview o the current state o hepatitis around the world and approaches that are being taken to address thisproblem in various countries. In some cases the articles had to be abridged slightly to t our ormat. Reerences and somepictures were also edited but will be included when the articles become available on the WGO website. In toto, the variousauthors provide a remarkable picture o this major public health problem and the need to attack it aggressively.
Hepatitis B Guideline
In May 2007, WGO will release a new Hepatitis B Guideline which will be distributed on the website and at UEGW 2007(and possibly AASLD 2007) in pocket ormat. This guideline will be developed using our “cascade” technique, whichprovides recommendations or management and treatment, regardless o what resources are available. The Project Team working on this guideline is chaired by Proessor Jenny Heathcote and includes a group o world-renowned hepatologistsrepresenting all regions o the globe.
Hepatitis Vademecum
 A compendium o the most important, reely accessible articles on viral hepatitis has been compiled. The list will be distrib-uted at our booth during DDW and is available on the WGO website.
National Member Society activities
 WGO member societies have answered the call to organise events on WDHD. A variety o additional activities related to World Digestive Health Day 2007: Viral Hepatitis will thereore take place around the world as organized by local membersocieties. We believe these projects are absolutely essential to publicize and educate the global community about the importance,prevalence and care o hepatitis. World Digestive Health Day is an important global educational event that has the power toimprove the quality o lie or millions o patients worldwide. We look orward to the active participation and support o our99 member societies and almost 50,000 individual members, as well as national and regional societies, government bodiesand industry.
World Digestive Health Day 2007—Viral Hepatitis
Henry Cohen, MD
Secretary General, WGO
Douglas R. LaBrecque, MD
 Treasurer, WGOWORLD DIGESTIVE HEALTH DAY: VIRAL HEPATITIS 3
Co-chairmen World Digestive Health Day
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...

Testez la base de données MICROMEDEX 30 jours de tests offerts => http://www.datec.lavoisier.fr/fr/

You must be to leave a comment.
Submit
Characters: ...